Efficient gene expression system using the RTP801 promoter in the corpus cavernosum of high-cholesterol diet-induced erectile dysfunction rats for gene therapy

Journal of Sexual Medicine

Volumn 5, Issue 6, 2008, Pages 1355-1364

  Lee, Minhyung ^a   Ryu, Ji Kan ^b   Piao, Shuguang ^b   Choi, Min Ji ^b   Kim, Hyun Ah ^a   Zhang, Lu Wei ^b   Shin, Hwa Yean ^b   Jung, Haeng In ^c   Kim, In Hoo ^c   Kim, Sung Wan ^d   Suh, Jun Kyu ^a,e  

^a Hanyang University   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d UNIVERSITY OF UTAH   (United States)

^e Inha University Hospital   (South Korea)

Author keywords

Corpus Cavernosum; Erectile Dysfunction; Gene Therapy; Hypercholesterolemia; Hypoxia Inducible Factor 1 ; Vector

Indexed keywords

CHOLESTEROL; CHOLIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; PROTEIN RTP801; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CHOLESTEROL DIET; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ERECTILE DYSFUNCTION; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC TRANSFECTION; HYPERCHOLESTEROLEMIA; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROMOTER REGION; RAT; UPREGULATION; WESTERN BLOTTING;

EID: 44949108250     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00771.x     Document Type: Article

References (35)

1. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral Sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-404.
2. Rendell MS, Rajfer J, Wicker PA, Smith MD, Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial. JAMA 1999; 281: 421-6.
3. Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE. Phosphodiesterase 5 inhibitors for erectile dysfunction. Ann Pharmacother 2005; 39: 1286-95.
4. Martinez-Jabaloyas JM, Gil-Salom M, Villamon-Fort R, Pastor-Hernandez F, Martinez-Garcia R, Garcia-Sisamon F. Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol 2001; 40: 641-6.
5. Gresser U, Gleiter CH. Erectile dysfunction: Comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil-Review of the literature. Eur J Med Res 2002; 7: 435-46.
6. Herrmann HC, Levine LA, Macaluso J Jr, Walsh M, Bradbury D, Schwartz S, Mohler ER III, Kimmel SE. Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results. J Sex Med 2006; 3: 303-8.
7. Melman A, Bar-Chama N, McCullough A, Davies K, Christ G. hMaxi-K gene transfer in males with erectile dysfunction: Results of the first human trial. Hum Gene Ther 2006; 18: 1165-76.
8. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther 1990; 1: 111-23.
9. Kabanov AV, Kabanov VA. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug Chem 1995; 6: 7-20.
10. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol Cell 1998; 2: 549-58.
11. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
12. Somia N, Verma IM. Gene therapy: Trials and tribulations. Nat Rev Genet 2000; 1: 91-9.
13. Moreland RB. Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10: 113-20.
14. Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, Donati S, Crescioli C, Zhang XH, Mirone V, Forti G, Maggi M. Effect ofchronic tadalafil administration on penile hypoxia induced by cavernousneurotomy in the rat. J Sex Med 2006; 3: 419-31.
15. Ryu JK, Cho CH, Shin HY, Song SU, Oh SM, Lee M, Piao S, Han JY, Kim IH, Koh GY, Suh JK. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006; 13: 705-15.
16. Ryu JK, Shin HY, Song SU, Oh SM, Piao S, Han JY, Park KW, Suh JK. Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia. Urology 2006; 67: 1329-34.
17. Xie D, Odronic SI, Wu F, Pippen AM, Donatucci CF, Annex BH. A mouse model of hypercholesterolemia-induced erectile dysfunction. J Sex Med 2007; 4: 898-907.
18. Xie D, Pippen AM, Odronic SI, Annex BH, Donatucci CF. Intracavernosal basic fibroblast growth factor improves vasoreactivity in the hypercholesterolemic rabbit. J Sex Med 2006; 3: 223-32.
19. Park K, Kim SW, Rhu KS, Paick JS. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model. J Sex Med 2006; 3: 996-1003.
20. Azadzoi KM, Park K, Andry C, Goldstein I, Siroky MB. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model. J Urol 1997; 157: 1011-7.
21. Park K, Siroky MB, Goldstein I. Relationship between atherosclerosis-induced cavernosal hypoxia and erectile dysfunction in the rabbit. Int J Impot Res 1996; 8: 104 (Abstract A22).
22. Lee M, Bikram M, Oh S, Bull DA, Kim SW. Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease. Pharm Res 2004; 21: 736-41.
23. Lee M, Lee ES, Kim YS, Choi BH, Park SR, Park HS, Park HC, Kim SW, Ha Y. Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system. Spine 2005; 30: 2729-34.
24. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R, Feinstein E. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002; 22: 2283-93.
25. Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta1 in human corpus cavernosum smooth muscle. J Urol 1995; 153: 826-34.
26. Lee M, Ryu JK, Oh SM, Lee E, Shin HY, Song SU, Kim SW, Suh JK. Water-soluble lipopolymer as a gene carrier to corpus cavernosum. Int J Impot Res 2005; 17: 326-34.
27. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum Gene Ther 1996; 7: 1947-54.
28. Lemkine GF, Goula D, Becker N, Paleari L, Levi G, Demeneix BA. Optimisation of polyethylenimine-based gene delivery to mouse brain. J Drug Target 1999; 7: 305-12.
29. Turunen MP, Hiltunen MO, Ruponen M, Virkamaki L, Szoka FC Jr, Urtti A, Yla-Herttuala S. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther 1999; 6: 6-11.
30. Nguyen HK, Lemieux P, Vinogradov SV, Gebhart CL, Guerin N, Paradis G, Bronich TK, Alakhov VY, Kabanov AV. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther 2000; 7: 126-38.
31. Lee M, Rentz J, Han SO, Bull DA, Kim SW. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther 2003; 10: 585-93.
32. Giuliano F, Rampin O, Bernabe J, Rousseau JP. Neural control of penile erection in the rat. J Auton Nerv Syst 1995; 55: 36-44.
33. Bivalacqua TJ, Usta MF, Kendirci M, Pradhan L, Alvarez X, Champion HC, Kadowitz PJ, Hellstrom WJ. Superoxide anion production in the rat penis impairs erectile function in diabetes: Influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2005; 2: 187-97.
34. Lee M, Choi D, Choi MJ, Jeong JH, Kim WJ, Oh S, Kim YH, Bull DA, Kim SW. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy. J Control Release 2006; 115: 113-9.
35. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp Mol Med 2004; 36: 1-12.